Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Supplements in PXE
NCT01525875Phase 2Completed
- Start
- Aug 2012
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of magnesium oxide in pseudoxanthoma elasticum (PXE). Started Aug 2012; status: completed.
02
Drugs
magnesium oxide
03
Conditions
pseudoxanthoma elasticum (PXE)
Beyond the preview
Go deeper on NCT01525875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525875.